Harald D. Rupprecht

Bayreuth, BY, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

Urine peptides enable non-invasive differential diagnosis of nodular diabetic nephropathy.

Urine peptides enable non-invasive differential diagnosis of nodular diabetic nephropathy.

Journal: Diabetes research and clinical practice

Published: April 09, 2026

Urinary Collagen Peptides Predict Mortality.

Urinary Collagen Peptides Predict Mortality.

Journal: Proteomics

Published: September 12, 2025

In silico prediction of optimal multifactorial intervention in chronic kidney disease.

In silico prediction of optimal multifactorial intervention in chronic kidney disease.

Journal: Journal of translational medicine

Published: July 31, 2025

Dysregulated Protease Homeostasis Defines Primary FSGS.

Dysregulated Protease Homeostasis Defines Primary FSGS.

Journal: Kidney360

Published: July 01, 2025

Association of Urinary Collagen Type III Degradation Product With Kidney Function and Fibrosis in Chronic Kidney Disease Patients.

Association of Urinary Collagen Type III Degradation Product With Kidney Function and Fibrosis in Chronic Kidney Disease Patients.

Journal: Proteomics

Published: November 29, 2024

Assessment and Risk Prediction of Chronic Kidney Disease and Kidney Fibrosis Using Non-Invasive Biomarkers.

Assessment and Risk Prediction of Chronic Kidney Disease and Kidney Fibrosis Using Non-Invasive Biomarkers.

Journal: International journal of molecular sciences

Published: February 07, 2024

Non-Invasive Biomarkers for Diagnosis, Risk Prediction, and Therapy Guidance of Glomerular Kidney Diseases: A Comprehensive Review.

Non-Invasive Biomarkers for Diagnosis, Risk Prediction, and Therapy Guidance of Glomerular Kidney Diseases: A Comprehensive Review.

Journal: International journal of molecular sciences

Published: February 07, 2024

Urinary peptidomic liquid biopsy for non-invasive differential diagnosis of chronic kidney disease.

Urinary peptidomic liquid biopsy for non-invasive differential diagnosis of chronic kidney disease.

Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association

Published: June 01, 2023

Differentiating primary and secondary FSGS using non-invasive urine biomarkers.

Differentiating primary and secondary FSGS using non-invasive urine biomarkers.

Journal: Clinical kidney journal

Published: May 17, 2023

Recent Advances in Urinary Peptide and Proteomic Biomarkers in Chronic Kidney Disease: A Systematic Review.

Recent Advances in Urinary Peptide and Proteomic Biomarkers in Chronic Kidney Disease: A Systematic Review.

Journal: International journal of molecular sciences

Published: April 13, 2023

Microangiopathy in multiple myeloma: a case of carfilzomib-induced secondary thrombotic microangiopathy successfully treated with plasma exchange and complement inhibition.

Microangiopathy in multiple myeloma: a case of carfilzomib-induced secondary thrombotic microangiopathy successfully treated with plasma exchange and complement inhibition.

Journal: BMC nephrology

Published: September 27, 2022

Predictive performance and clinical application of COV50, a urinary proteomic biomarker in early COVID-19 infection: a prospective multicentre cohort study.

Predictive performance and clinical application of COV50, a urinary proteomic biomarker in early COVID-19 infection: a prospective multicentre cohort study.

Journal: The Lancet. Digital health

Published: January 11, 2022

Showing 1-12 of 17

Last Updated: 09/26/2026